Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	7.09	49.54	46.26
Graham Fair Price	-34.72	34.07	52.19
PEG	599.28	-0.64	0.09
Price/Book	4.69	2.03	1.94
Price/Cash Flow	246.28	159.64	46.10
Prices/Earnings	156.95	37.13	14.45
Price/Sales	8.52	13.55	12.49
Price/FCF	246.28	159.64	46.10
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	0.91	0.73	0.72
Operating Margin	-22.91	0.14	0.18
ROA	-58.79	< 0.005	0.02
ROE	0.03	0.01	-59.26
ROIC	0.03	0.01	-59.48
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	< 0.005	0.08	-89.81
Dividends QOQ	< 0.005	< 0.005	-56.16
EBIT QOQ	0.33	-0.25	-24.13
EPS QOQ	1.59	-0.58	-63.25
FCF QOQ	1.19	-0.69	-41.52
Revenue QOQ	0.11	-0.03	-75.33
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	398.42	419.55	5.31
Days Sales Outstanding (DSO)	66.91	68.91	2.98
Inventory Turnover	0.23	0.21	-5.04
Debt/Capitalization	0.32	0.32	-0.10
Quick Ratio	0.65	0.66	1.13
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	60.03	61.39	2.27
Cash	2.00	1.92	-4.24
Capex	-0.30	-0.33	-9.06
Free Cash Flow	2.53	0.78	-69.08
Revenue	9.33	9.21	-1.34
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.61	1.66	2.65
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	8.55	8.85	3.43
Naive Interpretation	Member

06 - Financial Health · Weak

Rating